Michael J. Sofia

Insider Reports History

Entity
Individual
Location
C/O Arbutus Biopharma Corp., Suite 100, 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada
Signature
/s/ David C. Hastings as attorney-in-fact for Michael J. Sofia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael J. Sofia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arbutus Biopharma Corp Chief Scientific Officer Common Shares 1.49M $3.43M $2.31 Feb 2, 2024 Direct
Arbutus Biopharma Corp Chief Scientific Officer Common Shares 167K $387K $2.31 Feb 1, 2024 By Trust
Arbutus Biopharma Corp Chief Scientific Officer Stock Option (Right to Buy) 438K Feb 1, 2024 Direct

Insider Reports Filed by Michael J. Sofia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABUS Arbutus Biopharma Corp Feb 1, 2024 3 -$23.1K 4 Feb 5, 2024 Chief Scientific Officer
ABUS Arbutus Biopharma Corp Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Scientific Officer
ABUS Arbutus Biopharma Corp Jan 20, 2022 1 $801K 4 Jan 20, 2022 Chief Scientific Officer
ABUS Arbutus Biopharma Corp Dec 1, 2021 1 -$1.02M 4 Dec 3, 2021 Chief Scientific Officer